| The Unified Huntington’s Disease rating scale: Reliability and consistency KK al. Movement Disorders 11, 136-142, 1996 | 2067 | 1996 |
| Detection of Huntington’s disease decades before diagnosis: the Predict-HD study JS Paulsen, DR Langbehn, JC Stout, E Aylward, CA Ross, M Nance, ... Journal of Neurology, Neurosurgery & Psychiatry 79 (8), 874, 2008 | 953 | 2008 |
| Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin RK Graham, Y Deng, EJ Slow, B Haigh, N Bissada, G Lu, J Pearson, ... Cell 125 (6), 1179-1191, 2006 | 821 | 2006 |
| Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease MM Zeron, O Hansson, N Chen, CL Wellington, BR Leavitt, P Brundin, ... Neuron 33 (6), 849-860, 2002 | 747 | 2002 |
| Extrasynaptic NMDA receptor involvement in central nervous system disorders MP Parsons, LA Raymond Neuron 82 (2), 279-293, 2014 | 613 | 2014 |
| Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice AJ Milnerwood, CM Gladding, MA Pouladi, AM Kaufman, RM Hines, ... Neuron 65 (2), 178-190, 2010 | 613 | 2010 |
| N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease MMY Fan, LA Raymond Progress in neurobiology 81 (5-6), 272-293, 2007 | 518 | 2007 |
| A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington’s disease Huntington Study Group Neurology 57 (3), 397-404, 2001 | 508 | 2001 |
| Rate of functional decline in Huntington’s disease K Marder, H Zhao, RH Myers, M Cudkowicz, E Kayson, K Kieburtz, ... Neurology 54 (2), 452-452, 2000 | 462 | 2000 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 445 | 2012 |
| Palmitoylation of huntingtin by HIP14is essential for its trafficking and function A Yanai, K Huang, R Kang, RR Singaraja, P Arstikaitis, L Gan, PC Orban, ... Nature neuroscience 9 (6), 824-831, 2006 | 409 | 2006 |
| Regulation of ligand-gated ion channels by protein phosphorylation SL Swope, SJ Moss, LA Raymond, RL Huganir Advances in second messenger and phosphoprotein research, 49-78, 1999 | 391 | 1999 |
| Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function LA Raymond, VM André, C Cepeda, CM Gladding, AJ Milnerwood, ... Neuroscience 198, 252-273, 2011 | 374 | 2011 |
| Early synaptic pathophysiology in neurodegeneration: insights from Huntington's disease AJ Milnerwood, LA Raymond Trends in neurosciences 33 (11), 513-523, 2010 | 368 | 2010 |
| Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase LA Raymond, CD Blackstone, RL Huganir Nature 361 (6413), 637-641, 1993 | 330 | 1993 |
| Subtype-dependence of NMDA receptor channel open probability N Chen, T Luo, LA Raymond Journal of Neuroscience 19 (16), 6844-6854, 1999 | 320 | 1999 |
| Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity LA Raymond, CD Blackstone, RL Huganir Trends in neurosciences 16 (4), 147-153, 1993 | 316 | 1993 |
| Differential sensitivity of RecombinantN-Methyl-d-Aspartate Receptor subtypes to zinc inhibition N Chen, A Moshaver, LA Raymond Molecular pharmacology 51 (6), 1015-1023, 1997 | 294 | 1997 |
| Clinical markers of early disease in persons near onset of Huntington’s disease JS Paulsen, H Zhao, JC Stout, RR Brinkman, M Guttman, CA Ross, ... Neurology 57 (4), 658-662, 2001 | 266 | 2001 |
| Mutant huntingtin enhances excitotoxic cell death MM Zeron, N Chen, A Moshaver, ATC Lee, CL Wellington, MR Hayden, ... Molecular and Cellular Neuroscience 17 (1), 41-53, 2001 | 263 | 2001 |
